Profiling the neurovascular unit unveils detrimental effects of osteopontin on the blood–brain barrier in acute ischemic stroke
Профилирование нейроваскулярной единицы выявляет неблагоприятное влияние остеопонтина на гематоэнцефалический барьер при остром ишемическом инсульте
2022-06-25
SCID: 54.1/etmttqsb
Discuss with AI
EPAM-ia methodacute ischemic strokeblood-brain barrierneurovascular unitosteopontin
Figures from the paper
Abstract (AI)
Blood-brain barrier (BBB) dysfunction, characterized by degradation of BBB junctional proteins and increased permeability, is a crucial pathophysiological feature of acute ischemic stroke. Dysregulation of multiple neurovascular unit (NVU) cell types is involved in BBB breakdown in ischemic stroke that may be further aggravated by reperfusion therapy. Therefore, therapeutic co-targeting of dysregulated NVU cell types in acute ischemic stroke constitutes a promising strategy to preserve BBB function and improve clinical outcome. However, methods for simultaneous isolation of multiple NVU cell types from the same diseased central nervous system (CNS) tissue, crucial for the identification of therapeutic targets in dysregulated NVU cells, are lacking. Here, we present the EPAM-ia method, that facilitates simultaneous isolation and analysis of the major NVU cell types (endothelial cells, pericytes, astrocytes and microglia) for the identification of therapeutic targets in dysregulated NVU cells to improve the BBB function. Applying this method, we obtained a high yield of pure NVU cells from murine ischemic brain tissue, and generated a valuable NVU transcriptome database ( https://bioinformatics.mpi-bn.mpg.de/SGD_Stroke ). Dissection of the NVU transcriptome revealed Spp1, encoding for osteopontin, to be highly upregulated in all NVU cells 24 h after ischemic stroke. Upregulation of osteopontin was confirmed in stroke patients by immunostaining, which was comparable with that in mice. Therapeutic targeting by subcutaneous injection of an anti-osteopontin antibody post-ischemic stroke in mice resulted in neutralization of osteopontin expression in the NVU cell types investigated. Apart from attenuated glial activation, osteopontin neutralization was associated with BBB preservation along with decreased brain edema and reduced risk for hemorrhagic transformation, resulting in improved neurological outcome and survival. This was supported by BBB-impairing effects of osteopontin in vitro. The clinical significance of these findings is that anti-osteopontin antibody therapy might augment current approved reperfusion therapies in acute ischemic stroke by minimizing deleterious effects of ischemia-induced BBB disruption.
Key Findings
1
EPAM-ia produced high-yield, pure neurovascular unit cells and enabled construction of a stroke-specific NVU transcriptome database.
2
Osteopontin upregulation was confirmed by immunostaining in stroke patients and was comparable to that observed in mice.
3
Post-stroke anti-osteopontin treatment neutralized osteopontin, attenuated glial activation, preserved the blood–brain barrier, reduced edema and hemorrhagic transformation risk, and improved neurological outcome and survival.
4
Spp1, encoding osteopontin, was strongly upregulated across all investigated NVU cell types 24 hours after ischemic stroke.
5
The EPAM-ia method enables simultaneous isolation and analysis of endothelial cells, pericytes, astrocytes, and microglia from the same ischemic brain tissue.
Research Object
The neurovascular unit and blood–brain barrier in acute ischemic stroke, including endothelial cells, pericytes, astrocytes, and microglia
Research Subject
The detrimental effects of osteopontin upregulation and neutralization on neurovascular-unit function, BBB integrity and permeability, brain edema, hemorrhagic transformation, and neurological outcome after ischemic stroke
Publication Details
Publication Date
2022-06-25
Journal
Publisher
ISSN
Cited by
97
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai4
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq22014
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features2013
An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex2014
Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 20162019